rhGM-CSF vs placebo following rhGM-CSF-mobilized PBPC transplantation: A phase III double-blind randomized trial

Bone Marrow Transplantation

Volumn 19, Issue 3, 1997, Pages 209-213

  Legros, M ^a   Fleury, J ^a   Bay, J O ^a   Choufi, B ^a   Basile, M ^a   Condat, P ^a   Glenat, C ^a   Communal, Y ^a   Tavernier, F ^a   Bons, J M ^a   Chollet, P ^a   Plagne, R ^a   Chassagne, J ^a  

^a CENTRE JEAN PERRIN   (France)

Author keywords

PBPC; Placebo; rhGM CSF

Indexed keywords

CARBOPLATIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MELPHALAN; MITOXANTRONE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CELL TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ERYTHROCYTE TRANSFUSION; FEMALE; FEVER; HODGKIN DISEASE; HOSPITALIZATION; HUMAN; INFECTION; MALE; MYELOMA; NEUTROPHIL; NONHODGKIN LYMPHOMA; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SARCOMA; STEM CELL; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION; TESTIS CARCINOMA; THROMBOCYTE; THROMBOCYTE TRANSFUSION;

EID: 0031053547     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700640     Document Type: Article

References (24)

1. To LB, Roberts MM, Haylock DN et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9: 277-284.
2. Henon PR, Liang H, Beck-Wirth G et al. Comparisons of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplantation. Bone Marrow Transplant 1992; 9: 285-291.
3. Beyer J, Schwella N, Zingsem J et al. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison. J Clin Oncol 1995; 13: 1328-1335.
4. Editorial. Peripheral stem cells made to work. Lancet 1992; 339: 648-649.
5. Inaba T, Shimazaki C, Hirata T et al. Phenotypic differences of CD34-positive stem cells harvested from peripheral blood and bone marrow obtained before and after peripheral blood stem cell collection. Bone Marrow Transplant 1994; 13: 527-532.
6. Takamatsu Y, Akashi K, Harada M et al. Cytokine production by peripheral blood monocytes and T cells during haematopoietic recovery after intensive chemotherapy. Br J Haematol 1993; 83: 21-27.
7. Vose JM, Armitage JO. Clinical applications of hematopoietic growth factors. J Clin Oncol 1995; 13: 1023-1035.
8. Stahel RA, Jost LM, Cerny T et al. Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies. J Clin Oncol 1994; 12: 1931-1938.
9. Bolwell BJ, Goormastic M, Yanssens T et al. Comparison of G-CSF with GM-CSF for mobilizing peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant. Bone Marrow Transplant 1994; 14: 913-918.
10. Nemunaitis J, Rosenfeld CS, Ash R et al. Phase III, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 15: 949-954.
11. Gisselbrecht C, Prentice HG, Bacigalupo A et al. Placebo-controlled phase III trial of lenograstim in bone marrow transplantation. Lancet 1994; 343: 696-700.
12. Albin N, Douay L, Fouillard L et al. In vivo effects of GM-CSF and IL-3 on hematopoietic cell recovery in bone marrow and blood after autologous tranplantation with mafosfamidepurged marrow in lymphoid malignancies. Bone Marrow Transplant 1994; 14: 253-259.
13. Brice P, Divine M, Marolleau JP et al. Comparison of autografting mobilized peripheral blood stem cells with and without granulocyte colony-stimulating factor in malignant lymphomas. Bone Marrow Transplant 1994; 14: 51-55.
14. Bensinger WI, Longin K, Appelbaum F et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony-stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 1994; 87: 825-831.
15. Cortelazzo S, Viero P, Bellavita P et al. Granulocyte colony-stimulating factor following peripheral-blood progenitor-cell transplant in non-Hodgkin lymphoma. J Clin Oncol 1995; 13: 935-941.
16. Shimazaki C, Oku N, Uchiyama H et al. Effect of granulocyte colony-stimulating factor on hematopoietic recovery after peripheral blood progenitor cells transplantation. Bone Marrow Transplant 1994; 13: 271-275.
17. Klumpp TR, Mangan KF, Goldberg SL et al. Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial. J Clin Oncol 1995; 13: 1323-1327.
18. Spitzer G, Adkins DR, Spencer V et al. Randomized study of growth factors post-peripheral-blood stem-cell transplant: neutrophil recovery is improved with modest clinical benefit. J Clin Oncol 1994; 12: 661-670.
19. Colombat P, Delain M, Desbois I et al. Granulocyte-macrophage colonly-stimulating factor accelerates hematopoietic recovery after autologous bone marrow or peripheral blood progenitor cell transplantation and high-dose chemotherapy for lymphoma. Bone Marrow Transplant 1996; 18: 293-299.
20. Legros M, Fleury J, Curé H et al. New method for stem cell quantification: applications to the management of peripheral blood stem cell transplantation. Bone Marrow Transplant 1995; 15: 1-8.
21. To LB, Roberts MM, Haylock DN et al. Comparison of hematological recovery times and supportive requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9: 277-284.
22. Gorin NC, Coiffier B, Hayat M et al. Recombinant human granulocyte-macrophage colony stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's lymphoma: a double-blind, placebo-controlled trial. Blood 1992; 80: 1149-1157.
23. Besinger W, Appelbaum F, Rowley S et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995; 13: 2547-2555.
24. Vose M, Bierman PJ, Ruby E et al. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies. Bone Marrow Transplant 1996; 17: 951-956.